Effects of antithrombogenic agents on microvenous anastomoses in a rat model

Wayne J. Harsha, Ryan L. Kau, Namou Kim, Richard E Hayden

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Objective: To compare venous thrombosis rates among animals treated with aspirin, clopidogrel bisulfate, and ketorolac tromethamine using an anastomotic "tuck" model. Design: Single-blind randomized animal study. Setting: An animal laboratory at a tertiary care academic referral center. Subjects: Forty-two retired Lewis breeder rats divided into 3 equal groups. Interventions: Before surgical intervention, 1 group received aspirin (10 mg/kg) through gavage; 1 group, clopidogrel bisulfate (5 mg/kg) through gavage; and the final group, ketorolac tromethamine (3 mg/kg) through intramuscular injection. Each rat was then anesthetized, and the femoral veins were prepared bilaterally. A 180° venotomy was made, and the vessels were anastomosed with the tuck model set-up for anastomotic failure. The vessels were checked for patency every 15 minutes for 2 hours after clamp removal. Main Outcome Measures: The rate of venous thrombosis and the time to thrombosis. Results: In both the aspirin and clopidogrel groups, 2 of 28 vessels (7%) were thrombosed. Thrombosis occurred in 3 of 28 vessels (11%) in the ketorolac group (P=.86). All thromboses in the aspirin and clopidogrel groups took place at 7.5 minutes after clamp removal. In the ketorolac group, the mean time to thrombosis was 7.5 minutes (range, 0-22.5 minutes). There was no difference in time to thrombosis among the 3 groups (P=.86). Conclusion: Using a microvenous tuck model set-up for anastomotic failure, we found no difference in the rate of thrombosis or the time to thrombosis in rats pretreated with aspirin, clopidogrel, or ketorolac.

Original languageEnglish (US)
Pages (from-to)170-174
Number of pages5
JournalArchives of Otolaryngology - Head and Neck Surgery
Volume137
Issue number2
DOIs
StatePublished - Feb 2011

Fingerprint

clopidogrel
Thrombosis
Aspirin
Ketorolac
Ketorolac Tromethamine
Venous Thrombosis
Femoral Vein
Intramuscular Injections
Laboratory Animals
Tertiary Healthcare
Referral and Consultation
Outcome Assessment (Health Care)

ASJC Scopus subject areas

  • Otorhinolaryngology
  • Surgery

Cite this

Effects of antithrombogenic agents on microvenous anastomoses in a rat model. / Harsha, Wayne J.; Kau, Ryan L.; Kim, Namou; Hayden, Richard E.

In: Archives of Otolaryngology - Head and Neck Surgery, Vol. 137, No. 2, 02.2011, p. 170-174.

Research output: Contribution to journalArticle

@article{dc7566c0b9794574aaa8fe8352c04bd1,
title = "Effects of antithrombogenic agents on microvenous anastomoses in a rat model",
abstract = "Objective: To compare venous thrombosis rates among animals treated with aspirin, clopidogrel bisulfate, and ketorolac tromethamine using an anastomotic {"}tuck{"} model. Design: Single-blind randomized animal study. Setting: An animal laboratory at a tertiary care academic referral center. Subjects: Forty-two retired Lewis breeder rats divided into 3 equal groups. Interventions: Before surgical intervention, 1 group received aspirin (10 mg/kg) through gavage; 1 group, clopidogrel bisulfate (5 mg/kg) through gavage; and the final group, ketorolac tromethamine (3 mg/kg) through intramuscular injection. Each rat was then anesthetized, and the femoral veins were prepared bilaterally. A 180° venotomy was made, and the vessels were anastomosed with the tuck model set-up for anastomotic failure. The vessels were checked for patency every 15 minutes for 2 hours after clamp removal. Main Outcome Measures: The rate of venous thrombosis and the time to thrombosis. Results: In both the aspirin and clopidogrel groups, 2 of 28 vessels (7{\%}) were thrombosed. Thrombosis occurred in 3 of 28 vessels (11{\%}) in the ketorolac group (P=.86). All thromboses in the aspirin and clopidogrel groups took place at 7.5 minutes after clamp removal. In the ketorolac group, the mean time to thrombosis was 7.5 minutes (range, 0-22.5 minutes). There was no difference in time to thrombosis among the 3 groups (P=.86). Conclusion: Using a microvenous tuck model set-up for anastomotic failure, we found no difference in the rate of thrombosis or the time to thrombosis in rats pretreated with aspirin, clopidogrel, or ketorolac.",
author = "Harsha, {Wayne J.} and Kau, {Ryan L.} and Namou Kim and Hayden, {Richard E}",
year = "2011",
month = "2",
doi = "10.1001/archoto.2010.256",
language = "English (US)",
volume = "137",
pages = "170--174",
journal = "JAMA Otolaryngology - Head and Neck Surgery",
issn = "2168-6181",
publisher = "American Medical Association",
number = "2",

}

TY - JOUR

T1 - Effects of antithrombogenic agents on microvenous anastomoses in a rat model

AU - Harsha, Wayne J.

AU - Kau, Ryan L.

AU - Kim, Namou

AU - Hayden, Richard E

PY - 2011/2

Y1 - 2011/2

N2 - Objective: To compare venous thrombosis rates among animals treated with aspirin, clopidogrel bisulfate, and ketorolac tromethamine using an anastomotic "tuck" model. Design: Single-blind randomized animal study. Setting: An animal laboratory at a tertiary care academic referral center. Subjects: Forty-two retired Lewis breeder rats divided into 3 equal groups. Interventions: Before surgical intervention, 1 group received aspirin (10 mg/kg) through gavage; 1 group, clopidogrel bisulfate (5 mg/kg) through gavage; and the final group, ketorolac tromethamine (3 mg/kg) through intramuscular injection. Each rat was then anesthetized, and the femoral veins were prepared bilaterally. A 180° venotomy was made, and the vessels were anastomosed with the tuck model set-up for anastomotic failure. The vessels were checked for patency every 15 minutes for 2 hours after clamp removal. Main Outcome Measures: The rate of venous thrombosis and the time to thrombosis. Results: In both the aspirin and clopidogrel groups, 2 of 28 vessels (7%) were thrombosed. Thrombosis occurred in 3 of 28 vessels (11%) in the ketorolac group (P=.86). All thromboses in the aspirin and clopidogrel groups took place at 7.5 minutes after clamp removal. In the ketorolac group, the mean time to thrombosis was 7.5 minutes (range, 0-22.5 minutes). There was no difference in time to thrombosis among the 3 groups (P=.86). Conclusion: Using a microvenous tuck model set-up for anastomotic failure, we found no difference in the rate of thrombosis or the time to thrombosis in rats pretreated with aspirin, clopidogrel, or ketorolac.

AB - Objective: To compare venous thrombosis rates among animals treated with aspirin, clopidogrel bisulfate, and ketorolac tromethamine using an anastomotic "tuck" model. Design: Single-blind randomized animal study. Setting: An animal laboratory at a tertiary care academic referral center. Subjects: Forty-two retired Lewis breeder rats divided into 3 equal groups. Interventions: Before surgical intervention, 1 group received aspirin (10 mg/kg) through gavage; 1 group, clopidogrel bisulfate (5 mg/kg) through gavage; and the final group, ketorolac tromethamine (3 mg/kg) through intramuscular injection. Each rat was then anesthetized, and the femoral veins were prepared bilaterally. A 180° venotomy was made, and the vessels were anastomosed with the tuck model set-up for anastomotic failure. The vessels were checked for patency every 15 minutes for 2 hours after clamp removal. Main Outcome Measures: The rate of venous thrombosis and the time to thrombosis. Results: In both the aspirin and clopidogrel groups, 2 of 28 vessels (7%) were thrombosed. Thrombosis occurred in 3 of 28 vessels (11%) in the ketorolac group (P=.86). All thromboses in the aspirin and clopidogrel groups took place at 7.5 minutes after clamp removal. In the ketorolac group, the mean time to thrombosis was 7.5 minutes (range, 0-22.5 minutes). There was no difference in time to thrombosis among the 3 groups (P=.86). Conclusion: Using a microvenous tuck model set-up for anastomotic failure, we found no difference in the rate of thrombosis or the time to thrombosis in rats pretreated with aspirin, clopidogrel, or ketorolac.

UR - http://www.scopus.com/inward/record.url?scp=79952012682&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79952012682&partnerID=8YFLogxK

U2 - 10.1001/archoto.2010.256

DO - 10.1001/archoto.2010.256

M3 - Article

VL - 137

SP - 170

EP - 174

JO - JAMA Otolaryngology - Head and Neck Surgery

JF - JAMA Otolaryngology - Head and Neck Surgery

SN - 2168-6181

IS - 2

ER -